Axsome Therapeutics, Inc.Sales Agreement • December 2nd, 2019
Contract Type FiledDecember 2nd, 2019We have entered into a sales agreement, or the Sales Agreement, with SVB Leerink LLC, or SVB Leerink, dated May 9, 2019, relating to shares of our common stock, par value $0.0001 per share, offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $50.0 million from time to time through SVB Leerink, acting as our agent.